Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
---|
06/08/2011 | CN102085241A Chinese medicinal composition for fumigation treatment of skin diseases |
06/08/2011 | CN102085234A Liquorice dispersible tablets |
06/08/2011 | CN102085232A Astragalus dispersible tablets |
06/08/2011 | CN102085224A Method for preparing nano-level notoginseng root powder |
06/08/2011 | CN102085218A Injection for treating skin allergy and allergic asthma and preparation method thereof |
06/08/2011 | CN102085213A Ointment for treating burns and scalds |
06/08/2011 | CN102085165A Edible beauty mask powder and manufacturing method thereof |
06/08/2011 | CN102085164A Skin coating composition and uses thereof |
06/08/2011 | CN101862368B Medicament for treating leucoderma |
06/08/2011 | CN101716276B Preparation method of traditional Chinese medicine capsule for treating psoriasis |
06/08/2011 | CN101703732B Chinese medicinal ointment for treating herpes zoster and preparation method thereof |
06/08/2011 | CN101690753B Chinese medicament preparation for treating burn injuries and preparation method thereof |
06/08/2011 | CN101658518B Application of indirubin for preparing hair culture |
06/08/2011 | CN101654529B Preparation method and application of chitosan and/or metal composite of chitosan derivative |
06/08/2011 | CN101647958B Application of conic gymnadenia rhizome in restraining synthesis of skin melanin |
06/08/2011 | CN101632827B Traditional Chinese medicine composition for treating psoriasis and preparation method thereof |
06/08/2011 | CN101628115B Liquid medicine for treating empyrosis |
06/08/2011 | CN101590211B Pure Chinese medicinal oral preparation for treating psoriasis and preparation method thereof |
06/08/2011 | CN101590132B Whelk-removing liniment and preparation method thereof |
06/08/2011 | CN101569692B Compound health herb tea |
06/08/2011 | CN101554463B Drug for treating gynecologic and andrological diseases and preparation method thereof |
06/08/2011 | CN101337932B Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)amino-phenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these |
06/08/2011 | CN101219173B Traditional Chinese medicine for treating psoriasis and method for preparing the same |
06/08/2011 | CN101156939B A medicine for treating tinea manuum |
06/08/2011 | CN101137658B Antipruritic agent for pruritus caused by multiple sclerosis |
06/08/2011 | CN101080404B Pyrimidinylisoxazol derivative |
06/07/2011 | US7956187 Method for decreasing opioid metabolism |
06/07/2011 | US7956040 Combination of catechin and quercetin for pharmaceutical or dietary use |
06/07/2011 | US7955594 Polymers with structure-defined functions |
06/07/2011 | CA2483164C Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
06/07/2011 | CA2456977C Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies |
06/07/2011 | CA2435685C Desaturase genes and uses thereof |
06/07/2011 | CA2424483C Use of bromelain for the treatment of inflammatory diseases and for adjuvant therapy during wound healing processes |
06/07/2011 | CA2423868C Carbamic acid compounds comprising an amide linkage as hdac inhibitors |
06/07/2011 | CA2423190C Angiogenic agents and their uses |
06/07/2011 | CA2322954C Implantable particles for tissue bulking and the treatment of gastroesophageal reflux disease, urinary incontinence, and skin wrinkles |
06/07/2011 | CA2230556C Novel procollagens |
06/03/2011 | WO2011066506A1 2-METHYLENE-19,26-NOR-(20S)-1α-HYDROXYVITAMIN D3 |
06/03/2011 | WO2011065719A2 Topical composition for skin containing polysaccharide extract of red ginseng |
06/03/2011 | WO2011065657A2 Compound comprising extracts or fractions of chrysanthemum boreale makino having anti-inflammation activity |
06/03/2011 | WO2011065335A1 Preventing or ameliorating agent for hypersensitivity in sensitive skin |
06/03/2011 | WO2011064753A1 Pharmaceutical compositions and therapeutic applications of a hydrocortisone derivative designated as deina |
06/03/2011 | WO2011064657A2 Quinazolin-4(3a)-one derivatives and methods of use thereof |
06/03/2011 | WO2011064524A1 Dermatological compositions comprising a fat or oil of an essential fatty acid triglyceride |
06/03/2011 | WO2011064508A1 Use of a dipyridyl compound for treating rosacea |
06/03/2011 | WO2011064402A2 Acacia macrostachya seed extract and compositions containing same |
06/03/2011 | WO2011064401A2 Vigna unguiculata seed extract and compositions containing same |
06/03/2011 | WO2011063921A1 Acceleration of wound healing by a tissue inhibitor of metalloproteinases (timp) linked to glycosylphosphatidylinositol (gpi)-anchors |
06/03/2011 | WO2011063477A1 Fibronectin: growth factor chimeras |
06/03/2011 | WO2011063475A1 Methods of preparing hydrogels by enzyme catalysis and subsequent inactivation |
06/03/2011 | WO2011042684A3 Antimicrobial composition and method of controlling contamination or infections using said composition |
06/03/2011 | WO2011019239A3 Composition containing a natural extract |
06/03/2011 | WO2010122258A3 Method for producing free powder particles of polyamide impregnated with at least one cosmetic or pharmaceutical agent, and free powder particles of polyamide having a content of at least 25 wt % of at least one cosmetic or pharmaceutical agent |
06/03/2011 | WO2010057710A3 Process for the purification of heparan sulfate and use thereof in cosmetological and dermatological preparations |
06/03/2011 | CA2782048A1 Use of a dipyridyl compound for treating rosacea |
06/03/2011 | CA2781889A1 2-methylene-19,26-nor-(20s)-1.alpha.-hydroxyvitamin d3 |
06/03/2011 | CA2781474A1 Fibronectin: growth factor chimeras |
06/03/2011 | CA2780025A1 Dermatological compositions comprising a fat or oil of an essential fatty acid triglyceride |
06/03/2011 | CA2779353A1 Acceleration of wound healing by a tissue inhibitor of metalloproteinases (timp) linked to glycosylphosphatidylinositol (gpi)-anchors |
06/03/2011 | CA2776471A1 Surfactant-free, water-free, foamable compositions and breakable foams and their uses |
06/03/2011 | CA2687012A1 Compositions comprising igf1 agonists and uses thereof |
06/02/2011 | US20110130710 Treatment of abnormal or excessive scars |
06/02/2011 | US20110130705 Therapy for vitiligo |
06/02/2011 | US20110130704 Combination of a light ray and a lipase-bioconvertible compound for improving skin and/or hair appearance |
06/02/2011 | US20110130461 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
06/02/2011 | US20110130459 Composition for accelerated production of collagen |
06/02/2011 | US20110130453 Aminoalkylphenyl antagonists of prostaglandin d2 receptors |
06/02/2011 | US20110130442 Nucleic acid capable of controlling degranulation of mast cell |
06/02/2011 | US20110130436 Caspase inhibitors and uses thereof |
06/02/2011 | US20110130415 Protein kinase c inhibitors and uses thereof |
06/02/2011 | US20110130409 Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders |
06/02/2011 | US20110130396 Imidazothiadiazole derivatives |
06/02/2011 | US20110130382 Modulators of 5-ht receptors and methods of use thereof |
06/02/2011 | US20110130376 New no releasing steroids derivatives |
06/02/2011 | US20110130374 Small Pyrimidine Derivatives and Methods of Use Thereof |
06/02/2011 | US20110130372 Composition comprising estrone and hydrocortisone for use in the topical treatment of baldness |
06/02/2011 | US20110130364 Pyrrolopyridine derivatives substituted with cyclic amino group |
06/02/2011 | US20110130353 Highly purified antiendotoxin compound |
06/02/2011 | US20110130349 Compounds and Methods for Treating Toll-Like Receptor 2-Related Diseases and Conditions |
06/02/2011 | US20110130338 Use of serine protease inhibitors in the treatment of skin diseases |
06/02/2011 | US20110130324 Methods for systematic control of protein stability |
06/02/2011 | US20110130290 Thermoplastic paste for repairing living tissues |
06/02/2011 | US20110129883 Inactivation of genes of the mep pathway |
06/02/2011 | US20110129552 Acne Treatment |
06/02/2011 | US20110129547 Preparation for care and protection of skin with children and adults, method for obtaining thereof |
06/02/2011 | US20110129546 Dermatological pharmaceutical composition for the treatment of skin inflammation diseases, such as dermatitis, atopic dermatitis, vitiligo, alopecia areata, acne, psoriasis, pruritus or combinations of same |
06/02/2011 | US20110129534 Reduction of dermal scarring |
06/02/2011 | US20110129531 Dermal Fillers Comprising Silk Fibroin Hydrogels and Uses Thereof |
06/02/2011 | US20110129473 Vhnar anti-cytokine domains |
06/02/2011 | US20110129463 Quinazolin-4(3A)-One Derivatives and Methods of Use Thereof |
06/02/2011 | US20110129448 Methods to mobilize progenitor/stem cells |
06/01/2011 | EP2327784A2 Nucleic acids for inhibiting hairless protein expression and methods of use thereof |
06/01/2011 | EP2327712A2 Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides |
06/01/2011 | EP2327409A1 Tetracycline compound having target therapeutic activities |
06/01/2011 | EP2326668A1 Anti-il-12/il-23 antibodies |
06/01/2011 | EP2326647A1 6-substituted 2-(benzimidazolyl)purine and purinone derivatives and 6-substituted 2-(imidazoioý4,5- c¨pyridinyl)purine and purinone derivatives for immunosuppression |
06/01/2011 | EP2326330A1 Compositions for treating or delaying the onset of hair loss |
06/01/2011 | EP2326328A1 Use of dihydralazine for the treatment of diseases related to elevated semicarbazide sensitive amine-oxidase (ssao) activity |
06/01/2011 | EP2326326A2 Purin derivatives for use in the treatment of fab-related diseases |
06/01/2011 | EP2326315A1 Treatment of an autoimmune disease using il-18 antagonists |